Revenue segments as reported by the company.

Net revenue, before excise taxes

Excise taxes

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Sales and marketing

Research and development

General and administrative

Restructuring costs

Share-based payments

Depreciation and amortization

Impairment loss on goodwill and indefinite-lived intangible assets

Impairment loss on long-lived assets

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Cronos Group

Cronos Group, Inc. engages in the production and distribution of cannabis. Its brands include PEACE NATURALS, COVE, Spinach, Lord Jones, and PEACE+. The company was founded by Lorne Michael Gertner and Paul Rosen on August 21, 2012 and is headquartered in Toronto, Canada.

Earnings data Q4 2020

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Cronos Group, Inc. engages in the production and distribution of cannabis. I It operates through the Canada and Israel segments. The company was founded on August 21, 2012 and is headquartered in Toronto, Canada.

The third quarter earnings season isn’t getting off on the right foot for Cronos Group stock. Still, a key pivot toward the U.S.

Beneath the Q3 Setback Is an Opportunity for CRON Stock

Over the last six months, Cronos Group Inc. (NASDAQ: CRON) shares have fallen by  43.3%.

BofA: Cronos Group Has Potential To Be Long-Term Cannabis Leader

OrganiGram Holdings Inc.

Cannabis stocks traded lower on Tuesday after third-quarter earnings season in the group got off to a lackluster start.

Analyst: Big Cannabis Earnings Week Off To 'Rough Start'

Cronos Group Inc. (CRON) CEO Mike Gorenstein on Q3 2019 Results - Earnings Call Transcript

The Canadian cannabis producer's good news in Q3 wasn't as good as it might seem. But its bad news wasn't as bad as it might seem, either.

3 Things You Shouldn't Overlook With Cronos Group's Q3 Results

Cronos Group (CRON) earnings for the Canadian marijuana company's third quarter of the year have CRON stock down on Tuesday.
The post Cronos Group Earnings: CRON Stock Ticks 1% Lower on Q3 Results appeared first on InvestorPlace.

Cronos Group Earnings: CRON Stock Ticks 1% Lower on Q3 Results

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) posted third-quarter net revenue of CA$12.7 million ($9.6 million) Tuesday, up by 238% from CA$3.8 million in the same quarter of 2018.

Cronos Group Posts Q3 Revenue of CA$12.7 Million, Launches New CBD Brand PEACE+

Cronos (CRON) delivered earnings and revenue surprises of 33.33% and -3.05%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

Cronos Group (CRON) Reports Q3 Loss, Lags Revenue Estimates

This makes it tough for average investors to win with Cronos stock. On the other hand, high-short interest may mean its too late to go short CRON.

With Altria in the Driver’s Seat, It’s Tough to Play Cronos Stock

Aurora Cannabis

Aphria

HEXO Corp

Tilray Brands

Cannabis stocks had a huge showing on Wall Street last year. In fact, most of the news flow surrounding these stocks had investors pouring money into them.

Short Sellers Get Even Higher on Cannabis Stocks

Cronos Group Inc. CRON, -5.16% CRON, -5.06% said Tuesday it had a profit of C$788.4 million ($595.2 million), or 53 cents a share, in the third quarter, after a loss of C$7.2 million, or 4 cents a share, in the year-earlier period.

Cronos swings to profit as it books one-time gain, sales fall slightly short

Cronos earnings were positive, but may not be comparable. Sales jumped but missed views, a common problem for the industry.

Cronos Group Rises Despite Being Latest Marijuana Stock To Miss Sales Views

Chesapeake Energy

TimkenSteel

Some stocks stood out even as indexes were little changed.

Why Cronos Group, TimkenSteel, and Chesapeake Energy Slumped Today

Canopy Growth

CannTrust Holdings

A host of marijuana stocks report earnings this week, providing clear information on how the cannabis industry is progressing.

5 Marijuana Stocks to Watch This Week

GW Pharmaceuticals

You could have made a fortune buying these marijuana stocks right out of the gate. But is it too late to buy them now?

These 2 Marijuana Stocks Turned $10,000 Into Over $120,000 -- Are They Buys Now?

Some believe that Cronos stock overvalued. But if you consider cash on the balance sheet, CRON stock is more than reasonable.

Investors Should Use Other Metrics to Evaluate Cronos Group Stock

AbbVie

Innovative Industrial Properties

Although recreational weed captures headlines, the real money is on broadly accepted medicinal marijuana stocks.

10 Medical Marijuana Stocks to Cure Your Portfolio

Accurately testing for THC levels is proving to be a big challenge for law enforcement.

1 Massive Problem for the Cannabis Industry That Needs to Be Addressed Immediately

Is there promise or peril on the horizon for one of the most popular pot stocks in the world?

5 Questions Cronos Group Must Answer With Its Third-Quarter Report

Investors will focus on Cronos' (CRON) regular top and bottom-line numbers along with its pipeline progress, when it reports Q3 results.

Cronos (CRON) to Report Q3 Earnings: What's in the Cards?

Should investors think about buying some shares of Cronos (CRON) ahead of earnings, as a bet on a marijuana market comeback?

Buy Cronos (CRON) Stock Ahead of Earnings as Bet on Marijuana Comeback?

Like many other high quality pot stocks, CRON stock will eventually rebound from this sell-off, but not here, and not now. 
The post Cronos Stock Will Eventually Rebound, but Not Anytime Soon appeared first on InvestorPlace.

Cronos Stock Will Eventually Rebound, but Not Anytime Soon

The company's Australian medical cannabis asset has polished off its IPO.

Cronos Group Just Took a Big Leap Overseas

Plenty of excitement could be on the way this month for these three pot stocks.

3 Top Marijuana Stocks to Watch in November

These popular pot stocks should remain off-limits this month.

News for Cronos Group Stock (CRON)